Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Alexander Christ

Surgical Oncology Santa Monica, CA Medical Doctor

NPI 1427316702 CMS profile 4220725

1225 15Th St Ste 2100, Santa Monica, CA 90404

Open in the dashboard

General payments

$238,937

403 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Alexander Christ of Santa Monica, CA is reported in the CMS Open Payments database as having received $238,937 across 403 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Surgical Oncology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $102,186 106
2024 General $67,650 109
2023 General $39,940 122
2022 General $26,250 41
2021 General $2,038 16
2020 General $184 3
2019 General $690 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Alexander Christ
  • Surgical Oncology median
  • Middle half of Surgical Oncology
  • National median

In program year 2025, general payments to Alexander Christ were reported at $102,186. Among 1,137 Surgical Oncology profiles paid that year, the median was $288 and the middle half received between $118 and $1,346.

Show as a table
Year Alexander Christ Surgical Oncology median Middle half National median
2019 $690 $236 $86–$1,064 $163
2020 $184 $130 $47–$648 $114
2021 $2,038 $160 $53–$943 $132
2022 $26,250 $199 $76–$782 $149
2023 $39,940 $246 $95–$854 $160
2024 $67,650 $271 $106–$1,123 $164
2025 $102,186 $288 $118–$1,346 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Smith+Nephew, Inc. $66,302 87 payments
  2. Stryker Corporation $60,348 131 payments
  3. Globus Medical, Inc. $40,524 32 payments
  4. Zimmer Biomet Holdings, Inc. $27,564 70 payments
  5. Onkos Surgical, Inc. $19,089 26 payments
  6. Daiichi Sankyo Inc. $14,138 12 payments
  7. Encore Medical, LP $4,632 6 payments
  8. Uoc USA Inc $3,745 19 payments
  9. Medacta USA, Inc. $529 4 payments
  10. KCI USA, Inc $525 1 payment
  11. Other $1,541 15 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $160,628 61 payments
  2. Travel and Lodging $40,549 79 payments
  3. Education $20,981 12 payments
  4. Food and Beverage $13,779 249 payments
  5. Honoraria $3,000 2 payments
Products named General payments · program years 2019–2025
  1. REDAPT $50,895 33 payments
  2. TANDEM $46,814 27 payments
  3. MAKO $33,198 62 payments
  4. Genflex2 Total Knee System $29,375 8 payments
  5. POLARSTEM $29,046 19 payments
  6. REAL INTELLIGENCE $26,348 26 payments
  7. OR3O Dual Mobility $25,784 19 payments
  8. ELEOS LIMB SALVAGE SYSTEM $19,007 25 payments
  9. TRIATHLON $18,451 31 payments
  10. ANTHOLOGY $17,950 4 payments
  11. Other $143,232 235 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

13

Median for Orthopedic Surgery: 203

Drug cost

$10

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Amoxicillin Generic 13 $10

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 57 billing codes

Paid by Medicare

$150,567

Medicare's payments for the services billed

Medicare patients

333

Average age 73

Services billed

710

200 women, 133 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Depression 39%
Ischemic heart disease 35%
Chronic kidney disease 30%
Osteoporosis 29%
Diabetes 28%
Heart failure 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Turalio
  • Daiichi Sankyo Inc. $7,983
$7,983 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

403 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgical Oncology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record